UPC_APP_47163/2024

ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)

Procedural & sub-applicationsDocument Access (RoP262)Munich CDGenericWritten Phase

Overview Decisions Documents Timeline

Parties

Claimants

Dehns

Reps: Daniel Wise

Respondents

Amgen Inc.(Amgen Group)(Sanofi Group)
Sanofi-Aventis Deutschland GmbH(Amgen Group)(Sanofi Group)

Reps: Koen Bijvank

Judges

András KupeczJudge-Rapporteur

Patents

EP3666797

CPC codes: C07K2317/14, C07K2317/34, A61K39/395, A61K2039/505, A61K31/366, A61P3/06, A61K31/66, A61K31/22, A61P9/00, A61P7/00, A61P25/28, A61K2300/00…

Sector: Biotechnology

Outcome

Procedural only

Filed: Aug 14, 2024

First decided: Oct 22, 2024

Language: English

Open on UPC Registry